Andy Chen, M.D., Ph.D.

  • Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
  • OHSU Knight Cancer Institute, School of Medicine


Dr. Chen is a specialist in lymphoma and related malignancies. He is involved in research studying new treatments for lymphoma, and he has a particular interest in chimeric antigen receptor T cell (CAR-T) therapy. Dr. Chen attended Yale for college and then Harvard for his M.D. and Ph.D. in immunology research. He subsequently went to Stanford for residency and fellowship training before joining OHSU. He is past chair of the Patient Services Committee for the Oregon chapter of the Leukemia & Lymphoma Society and is co-chair of a national guideline committee for lymphoma.

Education and training

    • M.D., 2001, Harvard Medical School
    • Ph.D., 2001, Harvard University
  • Residency

    • Internal Medicine, Stanford University, 2004
  • Fellowship

    • Hematology, Medical Oncology, and Blood & Marrow Transplantation, Stanford University, 2008
  • Certifications

    • Hematology, American Board of Internal Medicine
    • Medical Oncology, American Board of Internal Medicine

Memberships and associations:

  • American Society of Hematology
  • American Society of Clinical Oncology
  • American Society for Transplantation and Cellular Therapy


Elsevier pure profile


  • {{[0].value }}